|
TSEN34 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.793800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.873400E-01 |
| Normal-vs-Stage2 |
2.383000E-01 |
| Normal-vs-Stage3 |
1.850610E-01 |
| Normal-vs-Stage4 |
1.734830E-01 |
| Stage1-vs-Stage2 |
6.301400E-01 |
| Stage1-vs-Stage3 |
7.744400E-02 |
| Stage1-vs-Stage4 |
1.740480E-02 |
| Stage2-vs-Stage3 |
5.996100E-02 |
| Stage2-vs-Stage4 |
7.948100E-02 |
| Stage3-vs-Stage4 |
6.315400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.609400E-01 |
| Normal-vs-AfricanAmerican |
1.341650E-01 |
| Normal-vs-Asian |
5.761400E-01 |
| Caucasian-vs-AfricanAmerican |
1.568800E-01 |
| Caucasian-vs-Asian |
5.598600E-01 |
| AfricanAmerican-vs-Asian |
4.224000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.451900E-02 |
| Normal-vs-Female |
1.190480E-02 |
| Male-vs-Female |
1.959320E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.559400E-01 |
| Normal-vs-Extreme_Weight |
1.136820E-01 |
| Normal-vs-Obese |
1.912440E-01 |
| Normal-vs-Extreme_Obese |
1.359340E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.134400E-01 |
| Normal_Weight-vs-Obese |
2.843800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.078000E-02 |
| Extreme_Weight-vs-Obese |
1.781670E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.157800E-02 |
| Obese-vs-Extreme_Obese |
2.422800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.595800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.723400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.293620E-01 |
| Normal-vs-Age(81-100Yrs) |
2.283000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.076830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.062100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.396400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.752400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.883040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.992800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.795800E-01 |
| Normal-VS-Type2 PRCC |
6.181000E-03 |
| Normal-VS-KIRP CIMP |
6.597800E-04 |
| Normal-VS-Unclassified PRCC |
9.686800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.644800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.75575134828432E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
8.855800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.439340E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.541900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.46889999999667E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.332800E-01 |
| Normal-vs-N1 |
2.794200E-02 |
| Normal-vs-N2 |
2.908000E-01 |
| N0-vs-N1 |
2.052300E-02 |
| N0-vs-N2 |
5.644200E-02 |
| N1-vs-N2 |
8.226600E-01 |
|
|
